| Abstrakt: |
A study conducted by the National Research Centre in Moscow, Russia, has revealed new findings on the Influenza A Virus. The researchers focused on nanobodies, which are a type of antibody that hold promise for combating infectious diseases. They isolated three broadly reactive nanobodies and modified them to improve their binding activity and interaction with a wider range of strains. One of the nanobodies, D9.2-Fc, showed a 100% protection rate against mortality in a mouse model. The researchers concluded that D9.2-Fc could serve as an effective antiviral agent against H3N2 influenza infection. [Extracted from the article] |
